Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

RDAGU vs ACET: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ACET Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 5–3 Matrix Metrics)

ACET Overall Winner 6-Pillar Tally: RDAGU 1 – 4 ACET (1 Tie) Matrix Metrics: RDAGU 3 – 5 ACET

As of Nov 20, 2026, Adicet Bio, Inc. (ACET) is the stronger overall head-to-head candidate over Republic Digital Acquisition Company Unit (RDAGU) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RDAGU carries a Unified Composite Score of 50.1/100 (HOLD) at $10.56 (N/M Forward P/E, N/A operating margin), whereas ACET carries 40.1/100 (SELL) at $2.14 (N/M Forward P/E, 0.0% operating margin).

  • Composite vs. Pillar Nuance: While RDAGU currently prints a higher short-term Unified Composite Score (50.1/100 HOLD vs. ACET 40.1/100 SELL), ACET captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (-100.0% vs. N/A YoY).
  • Technical & Structure Timing Caution: RDAGU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ACET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 13.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About RDAGU vs ACET
RDAGU NASDAQ
Republic Digital Acquisition Company Unit
Blank Checks
$10.56
+0.19% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.00β · 8% Vol
Unified Composite Score
50.1 / 100 HOLD
Tech 50.0 Fund 52.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
ACET NASDAQ Head-to-Head Winner
Adicet Bio, Inc. Common Stock
Pharmaceutical Preparations
$2.14
-13.01% 1D
Market Cap $23.0M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.93β · 60% Vol
Unified Composite Score
40.1 / 100 SELL
Tech 25.0 Fund 44.0 Flow 66.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -31.9%), weak momentum, RSI 14
RSI-14: 13.6 · SMA20: $3.07 · SMA50: $5.23

6-Pillar Scorecard Institutional Category Breakdown (RDAGU 1 – 4 ACET)

Columns: Metric · RDAGU · ACET
1. Valuation Multiples ACET
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M 0.82x
EV / Revenue N/M N/M
2. Growth & Scale ACET
Revenue Growth (YoY) N/A -100.0%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) N/A N/A
Market Cap N/A $23.0M
3. Profitability & Quality ACET
Gross Margin N/A N/A
Operating Margin N/A 0.0%
Net Profit Margin N/A 0.0%
Return on Equity (ROE) N/A -85.9%
4. Balance Sheet & Cash Flow ACET
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE $15M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning RDAGU
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) 230.4% (27th %ile)
Put/Call OI Skew N/A 1.41x (Put-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Blank Checks Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: RDAGU (3) vs ACET (5)
Institutional Metric RDAGU ACET Criterion Row Edge
Market Capitalization
Scale
N/A $23.0M Larger Scale ACET
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A -100.0% Higher Growth ACET
Operating Margin (TTM)
Profitability
N/A 0.0% Higher Margin ACET
Net Profit Margin
Profitability
N/A 0.0% Higher Margin ACET
Return on Equity (ROE)
Capital Efficiency
N/A -85.9% Higher ROE ACET
52-Week Range Position
Momentum
27% ($10–$12) 18% ($0–$10) Stronger Trend RDAGU
Beta / 30D Volatility
Risk Regime
0.00β · 8% Vol 1.93β · 60% Vol Lower Realized Risk RDAGU
Unified Institutional Score
Composite Signal
50.1 / 100 (HOLD) 40.1 / 100 (SELL) Higher Composite RDAGU
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 0.82x PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A ($15M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RDAGU +64.28 pp
RDAGU: +0.09% · ACET: -64.19%
3M Horizon ACET +449.5 pp
RDAGU: +1.05% · ACET: +450.55%
6M Horizon ACET +377.29 pp
RDAGU: -0.85% · ACET: +376.44%
1Y Horizon ACET +377.29 pp
RDAGU: -0.85% · ACET: +376.44%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RDAGU vs ACET. Trailing 12-month operating profitability (RDAGU N/A vs ACET 0.0%) and valuation multiples (RDAGU N/M vs ACET N/M Forward P/E) are benchmarked directly in Pillar 4 below.

RDAGU ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
ACET ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-85.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
RDAGU UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RDAGU Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ACET BREAKDOWN
122d in phase · OBV DISTRIBUTION
Current IV 230.4%
IV Percentile 27th %ile
Put/Call OI Skew 1.41x (Put-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact ACET Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
RDAGU Moat Profile Cyclical / Execution-Driven Positioning
Blank Checks Operator
Competes within the Blank Checks value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ACET Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $23.0M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ RDAGU vs ACET Key Questions & Quantitative Answers

As of Nov 20, 2026, Adicet Bio, Inc. (ACET) is the stronger overall head-to-head candidate over Republic Digital Acquisition Company Unit (RDAGU) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). RDAGU carries a Unified Composite Score of 50.1/100 (HOLD) at $10.56 (N/M Forward P/E, N/A operating margin), whereas ACET carries 40.1/100 (SELL) at $2.14 (N/M Forward P/E, 0.0% operating margin). Composite vs. Pillar Nuance: While RDAGU currently prints a higher short-term Unified Composite Score (50.1/100 HOLD vs. ACET 40.1/100 SELL), ACET captures the overall institutional head-to-head verdict (5–3 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (0.0% vs. N/A operating margin) and revenue trajectory (-100.0% vs. N/A YoY). Technical & Structure Timing Caution: RDAGU trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile ACET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 13.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

ACET leads the Growth & Scale pillar: RDAGU posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with ACET at -100.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin). On trailing 12-month operating scale, RDAGU generates N/A in USD-normalized revenue versus N/A for ACET. In operating R&D and SG&A reinvestment, RDAGU deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for ACET.

ACET screens cheaper on headline valuation multiples. RDAGU trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ACET trades at N/M Forward P/E, N/M Trailing P/E, 0.82x PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against RDAGU (N/A ROE) versus ACET (-85.9% ROE) capital efficiency.

In options market volatility and institutional positioning, RDAGU carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.00β · 8% Vol realized risk). By comparison, ACET carries 230.4% implied volatility (27th %ile, Balanced (25th–60th %ile)), a 1.41x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.93β · 60% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.